These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 7053260)

  • 21. Phase II clinical evaluation of AZQ in colorectal cancer.
    Bedikian AY; Stroehlein JR; Karlin DA; Korinek J; Bodey GP
    Am J Clin Oncol; 1982 Oct; 5(5):535-7. PubMed ID: 7180831
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A phase II study of aziridinylbenzoquinone (AZQ) in advanced large bowel carcinoma.
    Rubin J; van Hazel GA; Schutt AJ; Moertel CG; O'Connell MJ
    Am J Clin Oncol; 1982 Oct; 5(5):539-40. PubMed ID: 7180832
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phase II trial of mitoxantrone in previously untreated patients with colorectal adenocarcinoma: A Southwest Oncology Group Study.
    Cowan JD; Von Hoff DD; McDonald B; Talley RW; McCracken JD; Chen T
    Cancer Treat Rep; 1982 Sep; 66(9):1779-80. PubMed ID: 7116355
    [No Abstract]   [Full Text] [Related]  

  • 24. [Effect of polychemotherapy of cancer of the digestive organs].
    Singer Z; Kobylińska-Scieszkowa M; Dzieza-Lalowicz I; Starzewska H; Rogoń Z; Gejsler A
    Pol Tyg Lek; 1980 Sep; 35(38):1453-5. PubMed ID: 7465441
    [No Abstract]   [Full Text] [Related]  

  • 25. Phase II evaluation of 4'-epi-doxorubicin in patients with metastatic colorectal carcinoma.
    Ajani JA; Kanojia MD; Bodey GP
    Cancer Treat Rep; 1984 Dec; 68(12):1507-8. PubMed ID: 6595058
    [No Abstract]   [Full Text] [Related]  

  • 26. A phase 2 study of intermittent high-dose cyclophosphamide therapy of advanced gastrointestinal cancer.
    Schutt AJ; Hahn RG; Reitemeier RJ; Moertel CG
    Cancer Res; 1973 Oct; 33(10):2218-20. PubMed ID: 4741927
    [No Abstract]   [Full Text] [Related]  

  • 27. Schedule-selective biochemical modulation of 5-fluorouracil: a phase II study in advanced colorectal cancer.
    Sobrero AF; Aschele C; Guglielmi AP; Mori AM; Tixi LM; Bolli EA; Rosso R; Mammoliti S; Rollandi GA; Bertoglio S
    Clin Cancer Res; 1995 Sep; 1(9):955-60. PubMed ID: 9816066
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Phase I study of 5-fluorouracil and l-leucovorin].
    Sasaki T; Ota K; Wakui A; Akazawa S; Ogawa M; Ariyoshi Y; Yura J; Inagaki J; Hoshino A; Abe T
    Gan To Kagaku Ryoho; 1993 Mar; 20(4):485-91. PubMed ID: 8452386
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phase II study of sequential methotrexate-5-FU therapy in advanced measurable colorectal cancer.
    Cantrell JE; Brunet R; Lagarde C; Schein PS; Smith FP
    Cancer Treat Rep; 1982 Jul; 66(7):1563-5. PubMed ID: 7093972
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Combination chemotherapy of continuous infusion 5-FU and daily low-dose CDDP in colorectal carcinoma].
    Furuhata T; Hirata K; Yamamitsu S; Kimura H; Sasaki K; Hata F; Shirasaka T
    Gan To Kagaku Ryoho; 1999 Oct; 26(11):1554-8. PubMed ID: 10553412
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Individual 5FU-dose adaptation schedule using bimonthly pharmacokinetically modulated LV5FU2 regimen: a feasibility study in patients with advanced colorectal cancer.
    Ychou M; Duffour J; Pinguet F; Kramar A; Joulia JM; Topart D; Bressolle F
    Anticancer Res; 1999; 19(3B):2229-35. PubMed ID: 10472335
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phase II study of dibromodulcitol in colorectal, kidney, and other carcinomas.
    Mischler NE; Tormey DC; Klotz J; Borden EC; Ramirez G; Banerjee TK; Carr RM; Zaentz SD; Graf J
    Cancer Clin Trials; 1981; 4(4):407-10. PubMed ID: 7318122
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Baker's antifol in combination with 5-fluorouracil and methyl-CCNU in the treatment of metastatic colorectal cancer: a Southwest Oncology Group Study (Protocol 7764).
    Shaw MT; Bonnet JD; Wilson H; Heilbrun LK
    Cancer Treat Rep; 1980; 64(2-3):247-50. PubMed ID: 7407758
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [A late phase II study of raltitrexed (ZD 1694) in chemotherapy-naive patients with advanced colorectal cancer].
    Nishisho I; Kikkawa N; Ebata T; Osanai H; Ujiie S; Mitachi Y; Tsutsui M; Sawai K; Nishiguchi Y; Yasutake K; Wakasugi H; Wakui A
    Gan To Kagaku Ryoho; 2000 Jan; 27(1):81-91. PubMed ID: 10660737
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Optimal dosage of UFT in a weekday-on/weekend-off schedule as a postoperative adjuvant chemotherapy for colorectal cancer].
    Sadahiro S; Ohki S; Yamaguchi S; Takahashi T; Otani Y; Tsukikawa S; Yamamura T; Takemiya S; Nagasaki H; Nishiyama K; Fukushima T; Hiki Y; Yamaguchi S; Kumada K; Shimada H; Mitomi T; Makuuchi H;
    Gan To Kagaku Ryoho; 2000 Dec; 27(14):2223-30. PubMed ID: 11142166
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A phase II study of fluorodopan in the treatment of advanced colorectal cancer.
    Nair KG; Moayeri H; Mittelman A
    Cancer Treat Rep; 1980; 64(4-5):697-99. PubMed ID: 7427955
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Retrospective analysis on efficacy and toxicity of 5-fluorouracil (5-FU) and l-leucovorin (l-LV) in advanced or recurrent colorectal cancer].
    Chiba N; Yoshioka T; Kato S; Takahashi S; Shibata H; Kato S; Sakayori M; Otsuka K; Kakudo Y; Ohori H; Yamaura G; Takahashi M; Yasuda K; Ishioka C
    Gan To Kagaku Ryoho; 2005 Jul; 32(7):991-5. PubMed ID: 16044961
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phase II evaluation of cycloleucine in the treatment of patients with disseminated sarcomas.
    Baker LH; Fraile RJ; Samson MK; Cummings G
    Cancer Treat Rep; 1981; 65(3-4):358-9. PubMed ID: 7237461
    [No Abstract]   [Full Text] [Related]  

  • 39. [Clinical evaluation of S-1, a new anticancer agent, in patients with advanced gastrointestinal cancer. S-1 Cooperative Gastrointestinal Study Group].
    Maehara Y; Sugimachi K; Kurihara M; Taguchi T
    Gan To Kagaku Ryoho; 1999 Mar; 26(4):476-85. PubMed ID: 10097744
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chronomodulated infusion of cisplatin, 5-fluorouracil and folinic acid: lack of activity in advanced colorectal cancer.
    Natoli C; Scognamiglio MT; Martino MT; Irtelli L; De Tursi M; Cianchetti E; Mascitelli E; Tinari N; Iacobelli S
    Anticancer Res; 2000; 20(2B):1253-6. PubMed ID: 10810430
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.